TrialClinical cancer research : an official journal of the American Association for Cancer Research2025

A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer.

Angela K Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.